Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2005 Apr 26;106(4):1454–1459. doi: 10.1182/blood-2005-01-0368

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2005, The American Society of Hematology

PMC Copyright notice

Figure 3. — Histograms for cell volume and cell hemoglobin concentration at baseline and after treatment with Gardos channel blockers. Histograms for erythrocyte volume (RBC volume) and cell hemoglobin concentration (RBC HC) and plot of RBC HC (x-axis) versus RBC volume (y-axis) are presented at baseline (left side) and after the specified in vivo treatment (right side). Rows from top to bottom: control mouse before and after 11 days of treatment with clotrimazole (CLT, 80 mg/kg twice a day); 4.1^-/- mouse before and after 11 days of treatment with the vehicle use for drug administration; 4.1^-/- mouse before and after 11 days of treatment with CLT (80 mg/kg twice a day); 4.1^-/- mouse before and after 7 days of treatment with CDA (100 mg/kg twice a day); 4.2^-/- mouse before and after 6 days of treatment with CLT (160 mg/kg twice a day); and band 3^+/- mouse before and after 7 days of treatment with CLT (80 mg/kg twice a day). Data obtained with the Bayer ADVIA 120 hematology analyzer. One representative mouse shown for each condition; similar results were obtained for the other animals.